NGNE R&D Expenses
Neurogene Inc · R&D Expenses
NGNE R&D Expenses
Latest reported$88.50Mperiod ending
NGNE TTM R&D Expenses ($36.27M → $88.50M)
TTM R&D Expenses
High-resolution chart · PNG
NGNE r&d expenses history
Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.
| Period ending | R&D Expenses (USD) |
|---|---|
| 88,498,000 | |
| 82,396,000 | |
| 75,006,000 | |
| 69,714,000 | |
| 68,758,000 | |
| 65,136,000 | |
| 60,917,000 | |
| 57,754,000 | |
| 53,075,000 | |
| 47,652,000 | |
| 44,394,000 | |
| 42,211,000 | |
| 41,429,000 | |
| 42,064,000 | |
| 42,482,000 | |
| 42,241,000 | |
| 41,313,000 | |
| 40,181,000 | |
| 39,187,000 | |
| 37,214,000 | |
| 33,534,000 | |
| 28,553,000 | |
| 24,344,000 | |
| 21,445,000 | |
| 16,649,000 | |
| 11,811,000 | |
| 6,317,000 | |
| 2,901,000 | |
| 4,294,000 | |
| 22,285,000 | |
| 32,789,000 | |
| 42,876,000 | |
| 48,519,000 | |
| 40,998,000 | |
| 36,267,000 | |
| 32,840,000 | |
| 30,518,000 |